Skip to content

Sessions overview

  1. State of the art: the aim is to review all the available evidence generated in the field of haemostasis and liver disease
  2. Bleeding and invasive procedures: the aim is to debate about the impact of haemostatic alterations on the development of post-procedural complications and to discuss the optimal management of patients under anticoagulation undergoing invasive procedures
  3. Mechanisms of portal vein thrombosis (PVT) in cirrhosis: the aim is to discuss the newly generated evidence regarding the pathogenesis of PVT and to outline the best treatment strategy in liver transplant candidates with PVT
  4. Antiplatelet agents in patients with NASH: the aim is to discuss how to manage coronary artery disease in patients with liver disease-associated coagulopathy
  5. Vascular liver disease: this session is dedicated to update the knowledge and revise the new data on vascular liver disease pathophysiology, diagnosis and treatment
  6. Patients/nurses/ERN: the aim is to acknowledge the real need to empower patients and to include practitioner nurses and European regulatory agencies in order to advance in the knowledge of the field
  7. Controversies on management of thrombocytopenia: the aim is to discuss available strategies to treat patients with liver disease and low platelet levels
  8. Guidelines on coagulation and liver diseases: the aim is to discuss and compare recently published guidelines on management of bleeding and thrombosis in patients with liver disease
  9. Novelties in coagulation in liver diseases: this session aims to discuss recent studies evaluating coagulation in patients with liver disease
Back To Top